Patents Assigned to 21st Century Therapeutics, Inc.
  • Small molecules and methods of reducing injuries caused by radiation or chemicals
    Patent number: 11236056
    Abstract: A series of small molecule, radioprotective agents based on a compound of the general formula (I): or pharmaceutically acceptable salts thereof, wherein n is 1 or 2, and, independently, R is Br, Cl, H—O, H3C—S, and use of the compounds to protect healthy tissue/organs of subjects to reduce the injuries caused by radiation or chemicals.
    Type: Grant
    Filed: August 13, 2020
    Date of Patent: February 1, 2022
    Assignee: 21ST CENTURY THERAPEUTICS, INC.
    Inventor: Jiajiu Shaw
  • SMALL MOLECULES AND METHODS OF REDUCING INJURIES CAUSED BY RADIATION OR CHEMICALS
    Publication number: 20210087153
    Abstract: A series of small molecule, radioprotective agents based on a compound of the general formula (I): or pharmaceutically acceptable salts thereof, wherein n is 1 or 2, and, independently, R is Br, Cl, H—O, H3C—S, and use of the compounds to protect healthy tissue/organs of subjects to reduce the injuries caused by radiation or chemicals.
    Type: Application
    Filed: August 13, 2020
    Publication date: March 25, 2021
    Applicant: 21st Century Therapeutics, Inc
    Inventor: Jiajiu SHAW
  • Small-molecule TNF modulator to reduce the side effects of chemotherapy and radiotherapy
    Publication number: 20120082736
    Abstract: Cancer patients treated by chemotherapy and/or radiotherapy often suffer serious side effects. Currently, there is only one FDA approved and used as both a chemoprotector and a radioprotector, amifostine, which is associated with significant problems. Disclosed in the present invention are novel methods of using UTL-5g as both a chemoprotector and radioprotector for treating cancer patients in addition to other related methods.
    Type: Application
    Filed: September 25, 2011
    Publication date: April 5, 2012
    Applicants: GeneBlue Corporation, 21st Century Therapeutics, Inc.
    Inventor: Jiajiu SHAW